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including neurogenesis. The brain-enriched miR-124
has been assigned as a key player of neuronal differ-
entiation via its complex but little understood regula-
tion of thousands of annotated targets. To systemati-
cally chart its regulatory functions, we used CRISPR/
Cas9 gene editing to disrupt all six miR-124 alleles in
human induced pluripotent stem cells. Upon neuronal
induction, miR-124-deleted cells underwent neuro-
genesis and became functional neurons, albeit with
altered morphology and neurotransmitter specifica-
tion. Using RNA-induced-silencing-complex precipi-
tation, we identified 98 high-confidence miR-124
targets, of which some directly led to decreased
viability. By performing advanced transcription-fac-
tor-network analysis, we identified indirect miR-124
effectsonapoptosis, neuronal subtypedifferentiation,
and the regulation of previously uncharacterized zinc
finger transcription factors. Our data emphasize the
need for combined experimental- and system-level
analyses to comprehensively disentangle and reveal
miRNA functions, including their involvement in the
neurogenesis of diverse neuronal cell types found in
the human brain.
INTRODUCTION
The human brain comprises more than 300 neuronal cell types,
with an undetermined number of subtypes. Their underlying438 Cell Systems 7, 438–452, October 24, 2018 ª 2018 The Author(s
This is an open access article under the CC BY license (http://creativedevelopmental programs are mostly unknown. In recent years,
miRNAs have been identified as an important part of neurogen-
esis (A˚kerblom and Jakobsson, 2014). miRNAs bind in a
sequence-specific manner to mRNA transcripts and thereby
negatively interfere with the simultaneous translation of multiple
target transcripts by annealing predominantly at the 30 untrans-
lated region (UTR). miR-124 is one of themost abundant miRNAs
in the brain and is associated with processes such as neurogen-
esis (Lagos-Quintana et al., 2002; Landgraf et al., 2007), cancer
(Silber et al., 2008; Taniguchi et al., 2015), and the control of syn-
aptic functions in mature neurons in health (Dutta et al., 2013;
Hou et al., 2015; Rajasethupathy et al., 2009) and disease
(Fang et al., 2012; Lukiw, 2007) including cognitive impairment
(Gascon et al., 2014; Yang et al., 2014).
It remains unclear if miR-124 is controlling the initiation of
neuronal differentiation (A˚kerblom et al., 2012; Cao et al., 2007;
Cheng et al., 2009; Conaco et al., 2006; Makeyev et al., 2007;
Visvanathan et al., 2007; Yoo et al., 2009, 2011) or thematuration
and survival of the differentiated neurons (Franke et al., 2012; Gu
et al., 2014; Li and Ling, 2017; Sanuki et al., 2011; Xue et al.,
2016; Yu et al., 2008), or both. Knockdown studies using sponge
approaches (A˚kerblom et al., 2012) or antisense constructs
(Cheng et al., 2009; Conaco et al., 2006) resulted in decreased
neurogenesis. However, transcriptomic alterations from knock-
down approaches are mild and their interpretation difficult.
Gain-of-function experiments resulted in elevated neuronal dif-
ferentiation of mouse embryonic stem cells (Krichevsky et al.,
2006), HeLa cells (Lim et al., 2005), and glioblastoma cells (Silber
et al., 2008). Forced expression of miR-124 in combination
with miR-9 converts human fibroblasts into neuronal cell types
(Yoo et al., 2011), highlighting miR-124’s cell fate-determining
potency. Therefore, miR-124 was suggested to play a key role
during neuronal differentiation by promoting the exit from the
cell cycle, downregulating pro-proliferative genes, and activating). Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
neuron-specific genes (Conaco et al., 2006; Makeyev et al.,
2007; Visvanathan et al., 2007).
However, previous knockout studies in mouse models were
incomplete as not all three miR-124 paralogs, six alleles in total,
coding for identical mature miRNAs were ablated (Sanuki et al.,
2011). There is also a high heterogeneity of neuronal progenitor
cells in vivo, impeding studies of miR-124 in defined cell types
(Yaworsky and Kappen, 1999). Pooling heterogeneous cell types
that differ in their coding and non-coding transcriptome likely
results in incomplete views on miR-124’s complex regulatory
role with 4,024 computationally predicted targets as well as
additional potential non-canonical binding events (Chi et al.,
2012; Moore et al., 2015). So far, most studies have experimen-
tally validated only a single or very few miR-124 targets at once.
It remains unclear howmanymiR-124 targets are simultaneously
regulated within a cell and what their orchestrated impact is—
direct and also indirect—via gene regulatory cascades. There-
fore, it is essential to investigate miR-124’s functions in a well-
defined, homogeneous, and complete knockout model to over-
come the above-mentioned limitations.
We used a human induced pluripotent stem cell (hiPSC)-
based model system to mimic neurogenesis of bipolar neurons
under controlled and reproducible conditions (Busskamp et al.,
2014a). By CRISPR/Cas9 genome editing (Cong et al., 2013;
Mali et al., 2013), a full miR-124 knockout of all six genomic
copies was generated. By forced transcription factor (TF) induc-
tion, we rapidly and robustly induced neuronal differentiation in
wild-type (WT) andDmiR-124 cells. Subsequently, we performed
an in-depth molecular, cellular, and physiological characteriza-
tion of the DmiR-124 and isogenic WT lines, which revealed
altered morphological and functional features, different neuro-
transmitter specification, and decreased long-term viability.
We performed RNA-interacting protein immunoprecipitation
(IP) and subsequent sequencing (RIP-seq) (Malmevik et al.,
2015; Petri et al., 2017) to capture active miRNAs and their
mRNA targets bound to Argonaute-2 (AGO2), identifying
98 miR-124-regulated targets in parallel.
Cross-correlating RIP-seq experiments, miRNA quantifica-
tions, and time course RNA sequencing (RNA-seq) enabled us
to identify other miRNA species with increased activity upon
miR-124 deletion. Since we were mainly interested in functional
differences between TF networks in WT and DmiR-124 neurons,
we applied an advanced weighted topological overlap (wTO)
network analysis (Berto et al., 2016; Nowick et al., 2009), fol-
lowed by a co-expression differential network analysis (Gysi
et al., 2018). Using this computational approach, we were able
to detect similarities and specific differences in WT and DmiR-
124 neurogenesis at the level of genes and their regulatory con-
nections, including the impacts on neurogenesis of the unchar-
acterized TF ZNF787. Our results highlight the complexity of
the downstream effects of experimental miRNA manipulations.
RESULTS
Generation of a Human iPSC-Based miRNA-124
Knockout Model
Wewanted to studymiR-124 functionswith an emphasis on neu-
rogenesis in a robust, well-defined, and inducible neuronal cell
line derived from hiPSCs in which miR-124 is highly expressed(Busskamp et al., 2014a). This so-called inducible-neurogenin
cell line (iNGN) consists of stably integrated expression cas-
settes coding for the reverse tetracycline-controlled transactiva-
tor 3 (rtTA3) and the TFs neurogenin-1 and -2 (Neurog1/2), which
are driven from the doxycycline-inducible promoter (Figure 1A).
Hence, iNGN cells are hiPSCs, in which doxycycline administra-
tion triggers neurogenesis into a homogenous population of bi-
polar-shaped neurons within 4 days post induction (dpi), which
can be cultured for months and acquire robust functional prop-
erties (Lam et al., 2017).
To completely delete miR-124 in iNGN cells, we applied the
CRISPR/Cas9 technology (Ran et al., 2013) to knock out all three
genomic loci, six alleles in total, which encode for the identical
mature miR-124 sequence. We designed four unique gRNAs,
which in pairs flanked all miR-124 loci (Figure 1B; STAR
Methods). Transient expression of the Cas9 protein and gRNA
pairs in uninduced iNGN cells resulted in complete genomic de-
letions of all miR-124 loci (Figure 1C). We thoroughly compared a
monoclonal homogeneous DmiR-124 line with an isogenic
monoclonal iNGN control (WT) and detected no off-target effects
in top-predicted genomic sites by sequencing or chromosomal
alterations when karyotyping in theDmiR-124 cell line (Figure S1;
STARMethods). We observed miR-124 expression neither in the
DmiR-124 line as iPSCs (0 dpi) nor in neurons at 4 dpi (Figure 1D),
whereas in WT we measured an 18-fold increase in miR-124
expression: this demonstrates the successful generation of a
complete miR-124 knockout cell line.
miR-124 Loss Leads to Molecular and Phenotypic
Changes in Induced Neurons
We then characterized the effects of miR-124 deletion on neuro-
genesis by inducing neuronal differentiation inDmiR-124 andWT
cells. In both lines, we detected specific neuronal markers such
as MAP2, TUBB3, DCX, NEUN, and NCAM1 using immunocyto-
chemistry at 4 dpi, indicating the presence of neurons (Figures
2A and S2A). Next, we quantified representative protein levels
of pluripotency and neuronal lineage commitment by flow cy-
tometry. In both cell lines, the TRA-1-60 signal, a marker for plu-
ripotency, decreased, whereas the NCAM1 signal, a neuronal
marker, increased during the course of differentiation. In DmiR-
124 cells, signals for TRA-1-60 (p < 0.01 for 2 dpi and 3 dpi)
andNCAM1 (p < 0.05 for 1 dpi, 2 dpi, and 3 dpi) were significantly
lower (Figure 2B). Still, the DmiR-124 cells clearly differentiated
into neurons after induction of neurogenesis, suggesting that
neurogenesis in iNGN cells was independent of miR-124.
Microscopic analysis revealed that fewer DmiR-124 cells
became bipolar-shaped (i.e., normal WT morphology): the bipo-
lar neuronal fraction significantly decreased from 96.6% ± 0.3%
in WT to 71.3% ± 4.3% (p < 0.05) in DmiR-124 neurons, with
many DmiR-124 cells showing a more complex morphology at
4 dpi (Figures 2C and 2D). We analyzed neurite outgrowth, which
can correlate with differences in morphology, by time-lapse
microscopy: the outgrowth velocity was significantly reduced
(p < 0.05) to 0.66 ± 0.13 mm/min in DmiR-124 neurons compared
to 1.02 ± 0.11 inWT (Figures 2E and S2E), whereas overexpress-
ing (OE) miR-124 in DmiR-124 neurons reset the morphology to
97.6% ± 0.8% bipolar shape (p < 0.001; Figures 2F and S2B–
S2D). In addition, we found neurite outgrowth velocities compa-




Figure 1. Generation of an miR-124 Knockout Stem Cell Line
(A) Schematic illustration of the inducible neurogenin-1/2 (iNGN) stem-cell line in which neurogenesis from hiPSCs to post-mitotic neurons can be triggered
within 4 days.
(B) CRISPR-Cas9 miR-124 depletion strategy. All three miR-124 loci were targeted by four specific 50- and 30-flanking gRNAs as indicated by differently colored
triangles.
(C) Sanger sequencing results of miR-124 genomic loci. All six alleles were disrupted.
(D) qRT-PCR analysis indicated the lack of miR-124 expression in DmiR-124 cells, tested in iPSCs (0 dpi) and neurons (4 dpi). Statistical analysis was performed
using unpaired Student’s t tests with *p% 0.05, **p% 0.01. Data are represented as mean ± SEM.
See also Figure S1.(from 0.37 ± 0.11 mm/min to 1.11 ± 0.12 mm/min; p < 0.001; Fig-
ures 2G and S2F). Our data suggest that miR-124 deletion led to
phenotypic differences, which were reversible. Thus, miR-124
was dispensable for the general neuronal differentiation program
in WT and DmiR-124 iNGN cells but resulted in an increased and
reversible morphological heterogeneity. We confirmed that neu-
rogenesis was independent of the miR-124 knockout clone (Fig-
ure S2M), the underlying hiPSC line (Figures S2K–S2N), and
the TF-overexpression neuronal induction protocol, since an
alternative small molecule-based induction resulted in neurons
with equal efficiency within 21 dpi (Figures S2H–S2J) (Reinhardt
et al., 2013).
DmiR-124 Neurons Become Electrophysiologically
Active
As general neurogenesis was unaffected, we questioned
whether DmiR-124 iPSCs undergo functional neuronal matura-
tion. We tested the electrophysiological properties of WT and
DmiR-124 neurons and found that all WT cells (n = 12) fired ac-
tion potentials (APs) and that one fired multiple APs upon current
injection at 7 dpi (Figure 2H). At 14 dpi, 92% (n = 13) of WT cells
generated APs, with 31% AP firing trains. DmiR-124 cells gener-
ated APs as well: 92% (n = 13) at 7 and 14 dpi, with one cell firing
multiple APs at 14 dpi. Both cell lines showed similar capaci-
tance and membrane potential, suggesting similar cell sizes440 Cell Systems 7, 438–452, October 24, 2018and passive conductive properties (Figures 2I and 2J). However,
DmiR-124 cells were characterized by a lower voltage-depen-
dent peak current in a voltage range from 30 mV to +10 mV
at 14 dpi (p < 0.05; Figures 3K–3M) but showed similar steady
currents (Figures 2L and 2M) compared to WT cells. This peak
current shift in DmiR-124 neurons (Figures 2L and 2M) indicated
reduced sodium channel expression levels or altered channel
properties. In summary, our data suggest that both WT and
DmiR-124 neurons became functional, although with differences
in specific properties, suggesting that miR-124 has only a minor
impact on neuronal maturation.
Transcriptomic Differences in WT and DmiR-124
Neuronal Populations
In order to assess how the phenotypic differences were reflected
at the transcriptomic level, we used RNA-seq to assess tran-
scriptomic profiles of DmiR-124 and WT cells over the course
of neuronal differentiation between 0 dpi and 4 dpi (n = 7 bio-
logical replicates for each cell line per time point). In line with
our immunohistochemical analysis, key neuronal markers
(MAP2, TUBB3, PAX6, SOX1, and RBFOX3) were expressed in
DmiR-124, with small but significantly altered levels (padj < 0.05
and >1.5-fold) compared to WT (Figure 3A). As expected,
pluripotency genes decreased over 4 days. Sodium channels
were significantly decreased (padj < 0.05 and >1.5-fold)
A B
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Figure 2. Phenotypic Characterization of DmiR-124 versus WT Cells
(A) Immunostainings of indicated neuronal markers at 4 dpi and 0 dpi (hiPSC control).
(B) Loss of pluripotency (TRA-1-60) and neural lineage commitment (NCAM1) 0–4 dpi measured by flow cytometry using the surface markers indicated.
(legend continued on next page)
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(SCN2A/NaV1.2) or unchanged (SCN8A/NaV1.6), which may
explain the differences in peak currents (Figure 2M). WT iNGN
neurons have previously been characterized as co-transmitting
glutamate and acetylcholine as both neurotransmitter synthesis
and secretion pathways are upregulated at 4 dpi (Busskamp
et al., 2014a). Here, subtype-specific markers differed signifi-
cantly (padj < 0.05 and >1.5-fold) from a glutamatergic specifica-
tion (VGLU1/VGLU2/NMDA1) in WT to cholinergic in DmiR-124
cells (CHAT; Figure 3A).
We studied the overall changes in gene expression in the
absence of miR-124 by analyzing differential gene expression
patterns between WT and DmiR-124 over the course of neuro-
genesis (Figure S3A). We found 2,884 genes to be differentially
expressed at 0 dpi, 10,820 at 1 dpi, 10,897 at 2 dpi, 15,196 at
3 dpi, and 15,731 at 4 dpi (padj < 0.05; Figure S3A). These genes
were involved in differentiation, cell adhesion, morphogenesis,
and cell division.
Next, we analyzed the transcriptional differentiation course of
WT and DmiR-124 cells using a principal-component analysis
(PCA) of RNA-seq data (n = 7) (Figure 3B). Comparing the great-
est variance dimensions, individual replicates showed minimal
variance per time point. At 0 dpi, WT and DmiR-124 samples
clustered together, suggesting that both cell lines started from
a similar cellular ground state. From 1 dpi on, WT and DmiR-
124 samples diverged and took different paths during differenti-
ation. There was no common endpoint convergence at 4 dpi,
suggesting the presence of two distinct populations.
Using their transcriptomic profiles, we categorized WT and
DmiR-124 cells from different brain regions and developmental
stages. The expression profiles of 4 dpi WT and DmiR-124 neu-
rons were separately correlated with the Allen BrainSpan Atlas
dataset, which includes RNA-seq data from mixed cell popula-
tions acquired from 16 brain structures between 8 post-concep-
tion weeks (pcw) and 40 years of age (Miller et al., 2014). We
detected the highest correlation coefficients (Pearson correla-
tions > 0.3) between 8 and 37 pcw, suggesting that WT and
DmiR-124 neurons most closely represented prenatal neurons
(Figures 3C–3E; STAR Methods). Focusing on spatial informa-
tion, WT neurons correlated best with expression data from the
amygdaloid complex, cerebellar cortex, and hippocampus,
while DmiR-124 neurons were most similar to the cerebellar cor-
tex, hippocampus, and striatum (Pearson correlations > 0.39)
(Figures 3D and 3E). The differences between WT and DmiR-(C) Representative images of WT and DmiR-124 neurons at 4 dpi with differing m
(D) Quantification of bipolar morphology for WT and DmiR-124 neurons at 4 dpi.
(E) Quantification of neurite outgrowth velocities of WT and DmiR-124 neurons. n
(F) Quantification of bipolarity of DmiR-124 with and without miR-124 overexp
morphology (see also STAR Methods). n, number of independent samples.
(G) Quantification of neurite outgrowth velocities of DmiR-124 neurons at 5 dpi
miR-124 overexpression. n, number of neurites measured.
(H) Example traces and action potential (AP) quantification for 7 and 14 dpi of W
(I) Quantification of cell capacitance of WT and DmiR-124 neurons at 7 and 14 d
(J) Quantification of membrane voltage of WT and DmiR-124 at 7 and 14 dpi, an
(K–M) Quantification of peak and steady currents with example traces (K) at 7 and
are potassium-channel dominated.
Scale bars, 100 mm. Sample number, n, refers to the number of biological sample
cells as stated in (H) (H–M). Statistical analysis, unpaired Student’s t tests for two
*p% 0.05, **p% 0.01, ***p% 0.001. Data are represented as mean ± SEM.
See also Figure S2.
442 Cell Systems 7, 438–452, October 24, 2018124 neurons were also detected at later time points (7 dpi and
14 dpi, n = 3 biological replicates for each cell line per time point).
WT samples correlated also to prenatal cortical areas (Figures
S3B and S3C) and had higher correlation scores, suggesting
that these neurons aremore likely to be found in the human brain.
AGO2 Complex Precipitation Identifies Active
miRNA-mRNA Pairs
How is miR-124 linked to the aforementioned morphological and
functional differences between WT and DmiR-124 cells? As
miRNAs repress gene expression, we expected direct miR-124
targets to be upregulated after miR-124 deletion. Computational
predictions of miRNA target genes necessarily remain inconclu-
sive because one miRNA can bind to thousands of targets and
most mRNAs have multiple miRNA binding sites. There are
4,024 annotated human transcripts with miR-124 binding sites
(according to miRWalk with RNA22, Targetscan, and miRanda
databases) (Dweep et al., 2011; John et al., 2004; Lewis et al.,
2005; Miranda et al., 2006). Furthermore, the impact of miRNAs
on target gene repression has been found to bemostly moderate
(Baek et al., 2008; Guo et al., 2010b). Just focusing on mRNA
expression data may most likely be insufficient for a systematic
assessment of biologically active miR-124 targets as it would
also deliver many secondary and therefore indirect targets.
Thus, we used AGO2-RIP-seq to identify active miRNAs and
their targets in parallel. The physical binding of miRNA to their
mRNA targets occurs in the RNA-induced silencing complex
(RISC), in which AGO2 is one of the central enzymes (Liu et al.,
2004). IP of AGO2 includes bound miRNA and mRNA molecules
that can be identified by subsequent RNA-seq: we performed
this for both AGO2-IP and whole-cell samples (pre-IP whole-
cell RNA samples). We then conducted a differential AGO2-
precipitated concomitance analysis of mRNA and miRNA
molecules from WT and DmiR-124 samples. Subsequently,
we filtered for activemiR-124 targets (Figure 4A). For quality con-
trol, we checked for equal amounts of AGO2 protein levels
between samples (Figures S4A and S4B) and a decrease inmito-
chondrial mRNAs after IP (Figure S4C): these were expected as
mitochondrial RNA is not bound to the RISC. Furthermore,
miRNA, snoRNA, and snRNA levels were equal between WT
and DmiR-124 in whole-cell samples (Figure S4D).
Reads from AGO2-RIP-seq were mapped to the reference
genome, and regions surpassing a read threshold (see STARorphology.
n, number of independent samples.
, number of neurites measured.
ression at 4 dpi. The overexpression of miR-124 rescued the typical bipolar
with and without miR-124 overexpression. The impairment was rescued by
T and DmiR-124. APs were induced by current injection.
pi, indicating similar cell sizes for each time point.
indicator for potassium and proton channel activity.
14 dpi. Peak currents are sodium-channel dominated, whereas steady currents
s (B, D, and F), number of analyzed neurites (E and G), and number of recorded
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Figure 3. Transcriptomic Characterization of WT and DmiR-124 Neurons
(A) Heatmap of differentially expressed genes (RNA-seq, z scores, n = 7 biological replicates) for WT and DmiR-124 cells for selected neuronal and pluripotency
markers over the time course of differentiation. Asterisks mark significant differences between the cell lines (*padj < 0.05 and fold differenceR 1.5).
(B) Principal-component analysis showing the greatest variance dimensions of time course expression data from WT and DmiR-124 cells.
(C) Correlation analysis of WT and DmiR-124 neurons to the developing human brain. Pearson correlation of the 1,000 most differentially expressed genes
compared to the transcriptomic Allen BrainSpan Atlas dataset for the developmental stages from 8 to 37 postconceptional weeks (pcw). Abbreviations represent
brain regions: AM, amygdaloid complex; CC, cerebellar cortex; ST, striatum; HC, hippocampus.
See also Figure S3.
(D) Graphical illustration of the Allen BrainSpan Atlas analysis (C) for WT neurons at 4 dpi.
(E) Graphical illustration of the Allen BrainSpan Atlas analysis (C) for DmiR-124 neurons at 4 dpi.Methods) were considered as peaks. Peaks specific to WT sam-
ples were filtered out of the WT and DmiR-124 datasets. We
used transcript expression levels from whole-cell samples to
normalize RIP-seq signals (Sedlyarov et al., 2016; see STAR
Methods). 2,338 genes had significant peak region signals in
the WT but not in the DmiR-124 samples. We also analyzed for
differential gene expression, finding 1,909 genes with signifi-
cantly increased expression levels in WT compared to DmiR-
124 cells (padj < 0.05; Figure 4B). The AGO2-RIP-seq signals
did not recapitulate the distribution of WT and DmiR-124 wholecell RNA-seq samples, suggesting a different RISC-complex
occupation of available mRNAs (Figure S4F). By intersecting
these genes, we identified 127 transcripts with reduced 30 UTR
peaks (AGO2 IP) and increased expression in whole-cell
DmiR-124 samples, of which 98 (77.2%) were predicted to be
miR-124 targets (Figures 4B and 4C). 38 of the 98 targets had
previously been validated (Figure 4C; taken from miRTarBase;
marked in red) (Hsu et al., 2011). We used luciferase reporter as-
says to further test 45 30 UTRs, confirming that 43 filtered targets
were indeed miR-124 targets (Figures 4D and 4E). In summary,Cell Systems 7, 438–452, October 24, 2018 443
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Figure 4. Parallel Identification of miR-124 Targets by AGO2-RIP-Seq Analysis
(A) Schematic representation of the AGO2-RIP-seq experiment using AGO2 precipitation and subsequent sequencing of mRNAs and miRNAs to identify
active pairs.
(legend continued on next page)
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the AGO2-RIP-seq analysis enabled a comprehensive parallel
identification of 98 high-confidence active miR-124-targets
(81/98 validated) from the 4,024 annotated targets in iNGN neu-
rons (Figure 4E). However, this number most likely underesti-
mated the complete target repertoire, as our filters were quite
stringent and we did not capture any targets that were only regu-
lated at the protein level.
Increased miR-124 Target Expression Leads to
Decreased Neuronal Viability
We further analyzed the 98 high-probability targets to assess
their involvement in biological processes using a Gene Ontology
(GO) term analysis (Figure 4F). We detected that terms associ-
ated with synaptic maturation and apoptosis were enriched
among those target genes at 4 dpi (Figure 4F). AsDmiR-124 cells
became electrically active over time but had significantly
increased transcriptomic traces of apoptosis, we experimentally
investigated cell viability and apoptosis rates (caspase 3/7
activity) (Walsh et al., 2008) in WT and DmiR-124 neurons over
14 days in culture (Figures 4G and 4H). DmiR-124 cell viability
was significantly decreased from 4 dpi onward (p < 0.05), and
caspase 3/7 activity was significantly enhanced (p < 0.05) in
DmiR-124 compared to WT. The viability of DmiR-124 cells
over time was significantly increased by miR-124 supplementa-
tion (p < 0.05; Figure S4E), suggesting that miR-124 expression
is directly linked to neuronal survival. The 98 identified miR-124
targets remained increased in expression at 7 and 14 dpi (Fig-
ure S4F), and the associated GO terms further supported miR-
124’s impact on neuronal survival, specification, and maturation
(Figures S3D and S3E).
miRNA Transcriptome Dynamics upon miR-124
Depletion
We next investigated how the global miRNA expression profile
reacted to the depletion of a highly abundant miRNA species
such as miR-124. Previously, we had found that miR-124 repre-
sented about 80% of the miRNA profile in iNGN cells at 4 dpi
(Busskamp et al., 2014a). It has also been shown that a full
miRNA depletion, by knocking out key enzymes of the miRNA
processing machinery, can lead to downregulation of RISC pro-
tein members, including AGO2 protein levels (Busskamp et al.,
2014b; Martinez and Gregory, 2013). This results in an overall
decrease inmiRNA-mediated regulation. Therefore, we analyzed
whether the deletion of miR-124 in iNGN cells also resulted in an(B) Differentially expressed genes were filtered as shown in the Venn diagram. T
intersected with significantly upregulated transcripts in the whole-cell samples. 1
(C) 98 high-probability miR-124 targets filtered for 30 UTR peak signal decrease (
change standard error (lfcSE). Experimentally validated targets according to miR
reporter assays; color code indicates relative luciferase signal reduction upon m
(D) Venn diagram showing miRTarBase entries intersected with the 98 filtered m
(E) Pie chart, summarizing previous (miRTarBase), experimentally validated (lucif
(F) GO term enrichment analysis of filtered miR-124 targets indicating their involv
(G) Assessment of cell viability from 0 to 14 dpi. The percentage of live cells was m
live cells (AFC) and total cell fluorescence (AFC + R110) was examined and norm
(H) Assessment of apoptosis from 0 to 14 dpi. Luciferase activity corresponding
activity was normalized to the live cell fluorescence (AFC).
Statistical analysis, unpaired Student’s t tests with Holm-Sidak correction for m
mean ± SEM.
See also Figure S4.overall decrease in the miRNA machinery. However, we did not
detect any significant decreases in AGO2 protein levels (Figures
S4A and S4B). Therefore, miRNAs were likely still able to exert
their functions. In addition, we performed nCounter miRNA
quantifications of WT and DmiR-124 samples at 0 dpi and
4 dpi (n = 3 replicates per sample and time point) and found
similar count distributions at 0 dpi (Figure 5A). However, at
4 dpi, we detected a shift toward higher counts in DmiR-124
samples, suggesting that other miRNAs in DmiR-124 neurons
were increased in numbers (Figure 5B).
Next, we looked at miRNAs that were differentially expressed
in AGO2-RIP-seq samples. As expected, we found miR-124 to
be significantly downregulated at 4 dpi (Figure S5A). We put an
emphasis on upregulated miRNA species as these molecules
likely took over miRNA regulatory functions in DmiR-124 cells
(Figures 5C and S5A). As amplification biases occur massively
during small RNA-seq (sRNA-seq) library preparation (Hafner
et al., 2011; Linsen et al., 2009; Tian et al., 2010), we aimed at
combining our differential expression analysis of AGO2-RIP-
seq and sRNA-seq data with nCounter quantifications to filter
for both upregulated and sufficiently expressed miRNAs that
took over regulatory functions in the absence of miR-124. Eight
miRNA species had increased levels in AGO2-RIP-seq and
whole cell sRNA-seq DmiR-124 samples compared to WT and
more than 200 nCounter counts at 4 dpi (Figure 5D). Further-
more, these miRNAs showed enhanced association in the
AGO2 complex by normalizing to whole-cell signals and activity
ranking within the AGO2 complex (Figure S5B; STAR Methods).
Differences in miRNA expression ranking between WT and
DmiR-124 samples suggested new biologically active miRNA
regulations within the RISC in the absence of miR-124. We
looked for validated targets of these eight miRNAs and high-
lighted 12 genes with increased peak signal differences
(AGO2-RIP-seq) and significantly decreased expression levels
in whole cell samples in DmiR-124 samples compared to WT.
Our data indicated that these genes became regulated by other
miRNAs in the absence of miR-124. Performing a GO term anal-
ysis on their validated targets (miRTarBase) further suggested
involvement in neuronal morphology (Figure S5C).
Taken together, we revealed that the depletion of miR-124 re-
sulted in dynamic changes of actively expressed miRNAs taking
over regulatory actions on their corresponding target repertoire,
resulting in indirect effects on the coding and non-coding tran-
scriptome during neurogenesis.ranscripts with less 30 UTR signal in AGO2-IP data in DmiR-124 samples were
27 transcripts overlapped, of which 98 were annotated miR-124 targets.
left) and increase in expression (right). Data are presented as mean ± log2-fold
TarBase are indicated in red. 43 additional targets were validated by luciferase
iR-124 overexpression.
iR-124 targets.
erase reporter assays) and untested miR-124 targets.
ement in apoptosis and synaptic maturation.
easured using the ApoToxGlo assay. The ratio between fluorescence signal for
alized to 100% for 0 dpi.
to Caspase 3/7 activity was measured using the ApoToxGlo assay. Luciferase
ultiple comparisons with *p % 0.05, ***p % 0.001. Data are represented as









































































































































































Figure 5. Dynamic Co-regulatory Effects of Other miRNAs in the Absence of miR-124
(A and B) Density plots of normalized nCounter counts for WT and DmiR-124 at 0 dpi (A) and 4 dpi (B).
(C) Significant differentially expressed miRNAs from sRNA-seq with nCounter > 200 counts.
(D) Venn diagram of highly abundant miRNAs (nCounter > 200 counts) that were upregulated in DmiR-124 and showed higher AGO2 signals in DmiR-124
compared to WT.
(E) Increased AGO2-RIP signals and decreased log2-fold changes for miRNA targets shown in (D) that were previously validated (miRTarBase). Data are
represented as mean ± SEM.A Network of Transcription Factors Is Influenced by
miR-124
A significant fraction of the identified miR-124 targets (24/98,
p < 0.05; c2 test) coded for TFs, suggesting that miRNA-124
exerts much of its impact via influencing gene regulatory cas-
cades involving many TFs. Measuring indirect miRNA effects is
not trivial (Hill et al., 2014) but essential to understanding the
full spectrum of miRNA regulation. We conducted a time-lapse
network analysis focusing on the 24 miR-124 targets coding
for TFs to understand themiR-124 regulatory network underlying
neurogenesis.
For each time point and, separately, for WT and DmiR-124
cells (n = 7 for each time point), we identified genes that corre-
lated with the 24 TFs. Correlated genes represent potential
target genes or interaction partners of TFs. To reveal how similar
TFs were to their correlated target genes, we calculated wTO
networks for all expressed TFs for each time point for WT and
DmiR-124 cells separately (Figures 6A, S6A, S7A, and S7B).
Nodes in these wTO networks represent TFs, and they are con-
nected by a link if they share a significant number of correlated
genes, that is, are likely acting together in regulating their target
genes. One advantage of wTO networks is that they result in
more robust definitions of connections and interactions among
genes than simple correlation networks because they suppress
false positive inferences (Carlson et al., 2006; Gysi et al., 2017;
Nowick et al., 2009; Ravasz et al., 2002). In contrast to the widely446 Cell Systems 7, 438–452, October 24, 2018used weighted gene co-expression network analysis (WGCNA)
(Zhang andHorvath, 2005), the wTO network that we have devel-
oped accommodates both positive and negative correlations,
which are essential for analyzing TFs as they have both
enhancing and repressing functions (Gysi et al., 2017; Nowick
et al., 2009). Furthermore, our method also assigns p values to
each link, resulting in a high-accuracy network based on seven
replicates, which is important for comparing networks with
high confidence (Gysi et al., 2017). At 0 dpi, WT and DmiR-124
networkswere identical. They started to differ from 1 dpi, peaked
in differences at 3 dpi (Figure 6A), and decreased in differences
at 4 dpi (Figures S7A and S7B). To reveal the contrast between
the WT and DmiR-124 networks, we subtracted the wTO of
DmiR-124 from the wTO of WT, resulting in differential networks
(Figures 6A and S7A, top). In WT cells, a number of links were
reactivated at different time points, while in the DmiR-124 cells
most links were unique, suggesting the presence of different
regulatory modes and global changes after miR-124 loss
(Figure S7C). We classified the differentially expressed TFs
(14.95%, n = 3,145) using a self-organizing map (SOM) algorithm
(Figures 6B and S7D). The SOM categories with a steady in-
crease in differential expression over time were considered to
be the best candidates for also being influenced by miR-124,
as they were expected to be upregulated in the absence of the
negative regulator (Figures 6B and S7D). Most miR-124 targets





(legend on next page)
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the monotonically increasing SOM categories, which is in line
with the lack of repressing miR-124 (Figures 4B and S7D): the
targets previously described included PTBP1, which was identi-
fied as an important factor within our co-expression network
(Figure 6A). Nodes including GLIS2, SERTAD3, and TP73 ap-
peared to be very important as these genes fulfilled all criteria:
they were filtered and validated targets (Figure 4C), were top
hits in the network analysis, and followed a rising trend in the
SOM clustering.
We focused specifically on 3 dpi, aswedetectedmost network
activity at this time point (Figures 6A, S7C, and S7D). We also
found some miR-124 targeted TFs with unknown functions
(ZNF787) as well as human-specific indirectly targeted ones
(ZNF138) within the dense 3 dpi network of the DmiR-124 sam-
ples (according to Uniprot; Nowick et al., 2011). Exemplarily, in-
dividual nodes around the miR-124 target ZNF787 and con-
nected ZNF138 (Figure 6C) as well as their associated genes
(Figure 6D) were extracted from our wTO analysis. This visualiza-
tion emphasizes how embedded ZNF787 was within the gene
regulatory network upon miR-124 deletion at 3 dpi. Next, we
aimed at perturbing the ZNF787 node by OE ZNF787 robustly
in WT iNGN cells (Figure 6E). WT-ZNF787-OE cells underwent
neurogenesis and were positive for the neuronal marker MAP2
(Figure 6F). We performed GO term analyses on differentially ex-
pressed genes betweenWT andWT-ZNF787OE (n = 3 biological
replicates, 4dpi). Specifically, focusing ondownregulated genes,
many neuronal biological processes were significantly inhibited
(Figure 6G). Hence, our data indicated that ZNF787 represents
a neuronal feature repressor. Looking at ZNF787-associated
genes derived from our wTO analysis, corresponding expression
levels massively differed between WT, DmiR-124, and WT-
ZNF787-OE (Figure 6H). In particular, 51 out of 78 ZNF787-asso-
ciated genes showed a similar expression trend for DmiR-124
and WT-ZNF787-OE in comparison to WT (Spearman correla-
tion, R = 0.498 with p < 0.001; Pearson correlation, R = 0.277
with p = 0.01). This further highlights ZNF787’s impact on the
gene regulatory network when its expression was increased
due to miR-124 deletion or when overexpressed. However,
ZNF787’s overexpression did not hamper neurogenesis per se
as the cells were still positive for MAP2 (Figure 6F).
In summary, our wTO analysis suggested that the TF networks
were globally altered and differentially connected, especially atFigure 6. Target-TF-Network Analysis Indicates Indirect—TF-Mediated
(A) Expression correlation as weighted topological overlap (wTO) between TFs tha
forWT (middle),DmiR-124 (bottom), and the difference (top). The opacity of the line
SOM cluster as shown in Figure 6B. Underlined TFs are filtered miR-124 targets
(B) Loess regression from self-organizingmaps calculated on the basis of normaliz
code represents the SOM clusters. Only four categories are shown (See also Fig
(C) Illustration of a miR-124 target-specific wTO subnetwork showing TF nodes
associated genes.
(D) Illustration of the subnetwork shown in (C), including underlying associated g
(E) Quantification of ZNF787 overexpression (OE) efficiency in WT neurons ove
Student’s t tests with Holm-Sidak correction for multiple comparisons with ***p%
(F) Representative immunostainings for DAPI and the neuronal marker MAP2. Sc
(G) GO term enrichment analysis of significantly downregulated transcripts (pad
impact on repressing neuronal differentiation and maturation.
(H) Heatmap of ZNF787-associated genes reappearing in target-wTO networks
formed counts, n = 3 biological replicates). Arrows indicate similar expression tre
See also Figures S6 and S7.
448 Cell Systems 7, 438–452, October 24, 20183 dpi upon miR-124 depletion. In addition, our analysis identified
uncharacterized TFs—of which ZNF787was experimentally vali-
dated—having regulatory functions during neurogenesis.
GO Term Analysis of wTO Network Nodes Reveals
Indirect miR-124 Functions
We next investigated which biological functions were controlled
by the TF networks of WT and DmiR-124 cells at each time point,
especially which functions were common or different between
the networks. To this end, we used our co-expression differential
network analysis tool (Gysi et al., 2018) and classified each cor-
relation into common or specific connections (Figures 7A–7C
and S6B). Subsequently, we performed GO enrichment tests
for these categories to reveal the biological processes the under-
lying genes were involved in.
GO groups that were common between theWT and DmiR-124
networks at 0 dpi included, for example, ‘‘mRNA processing,’’
‘‘cell division,’’ and ‘‘mitotic cell cycle’’ (Figure 7A; Table S1). In
particular, WT andDmiR-124 networks shared the groups ‘‘regu-
lation of asymmetric cell division’’ and ‘‘regulation of extracellular
matrix disassembly’’ at 1 dpi and ‘‘synapse assembly,’’ ‘‘regula-
tion of synapse organization,’’ and ‘‘positive regulation of neuro-
logical system process’’ at 4 dpi, indicating that aspects of neu-
rogenesis were also present in DmiR-124 cells.
However, we also found groups that were specific to the WT
network. For example, the GO terms ‘‘layer formation in cerebral
cortex’’ and ‘‘pyramidal neuron development’’ at 1 dpi, ‘‘regula-
tion of exit from mitosis’’ and ‘‘positive regulation of long-term
neuronal synaptic plasticity’’ at 2 dpi, ‘‘positive regulation of den-
dritic cell differentiation’’ at 3 dpi, and several ‘‘mRNA process-
ing’’ groups at 4 dpi were different (Table S1). Many metabolic
terms and cell signaling pathways (Wnt signaling at 3 dpi) were
also specific toWT cells (Figure 7B). This indicates that particular
functions related to cell-cycle control and neuronal differentia-
tion started to be differentially controlled in WT and DmiR-124
cells right from the beginning of neurogenesis.
DmiR-124 groups differed in ion incorporation and diverse
metabolic processes at 1 and 2 dpi and ‘‘signal transduction re-
sulting in induction of apoptosis,’’ ‘‘positive regulation of long-
term neuronal synaptic plasticity,’’ ‘‘regulation of dendritic spine
morphogenesis,’’ and ‘‘striatal medium spiny neuron differentia-
tion’’ at 3 dpi (Figure 7C). In contrast to Wnt signaling in WT, we—miR-124 Regulatory Actions
t were differentially expressed at 3 dpi. Every panel shows the network at 3dpi
s indicates thewTO value of that link. Colored gene names represent a specific
(Figures 4B and 4C).
ed fold changes of permanently (1 dpi–4 dpi) differentially expressed TFs. Color
ure S7D).
at 3 dpi. Colored lines indicate negative or positive correlations of underlying
enes.
r time. n = 3 biological replicates. Significance was assessed with unpaired
0.001. Data are represented as mean ± SEM.
ale bar, 50 mm.
j < 0.05, log2-fold change < [1]) upon ZNF787 overexpression indicating its
for WT, DmiR-124, and WT-ZNF787-OE (RNA-seq, z scores from rlog-trans-
nds for DmiR-124 versus WT and WT-ZNF787 overexpression versus WT.
A B C
Figure 7. Semantic Clustering of GO Terms Reveals Shared and Different Biological Processes at 3 dpi in WT and DmiR-124 Cells
(A–C) Co-expression differential network analysis of shared (A), WT-specific (B), or DmiR-124-specific (C) regulated genes at 3 dpi. Underlying biological pro-
cesses are grouped and highlighted. See also Figure S6.detected phosphatidylinositol 3-kinase signaling in DmiR-124
groups. In particular, the GO term ‘‘striatal medium spiny neuron
differentiation’’ was in line with the BrainSpan analysis (Figures
3C–3E). Our analysis further suggested that the differences in
cell fate regulation weremediated by the alteredmiR-124-dysre-
gulated TF networks in DmiR-124 cells at 3 dpi.
Our regulatory network analysis of the TFs, which are direct
miR-124 targets, revealed clear differences in network architec-
ture between WT and DmiR-124 samples: these increased until
the cells become post-mitotic. These complex relationships,
that is, indirect miR-124 functions, would have been impossible
to detect by miR-124 target analysis alone. Moreover, biological
functions underlying these regulatory network differences are in
line with the phenotypic differences we observed when miR-124
was deleted.
DISCUSSION
Here, we present the first complete cellular human miR-124
knockout model. Previously, only a partial (one locus) miR-124
knockout mouse model had been studied, which showed small
brain sizes, axonal mis-sprouting, and enhanced apoptosis (Sa-
nuki et al., 2011), of which the latter is in line with our findings.
However, by a partial knockout, compensatory effects driven
by miR-124 paralogs could not be ruled out, and hence only
very few of the potential miR-124 targets were identified. In light
of previous studies, our findings are quite unexpected, as the
initiation of neurogenesis appears to be miR-124-independent.
We identified differences in metabolism and cell-fate regulation.
For instance, we found that DmiR-124 neurons possess higher
cholinergic neurotransmitter identity and are more similar to
developing human striatum cells, which could be mechanisti-
cally explained through a co-expression differential network
analysis. Hence, our systems-level analysis of regulatory miR-
124-TF networks revealed that miR-124 impacts neuronal sub-
type differentiation.
Previous studies associatedmiR-124with one or a few specific
targets responsible for phenotypic changes. We experimentallyverified 98 high-confidence targets, confirming that miR-124
acts at a ‘‘network-level’’ rather than controlling only one or a
few genes. Still, the fact that we ‘‘only’’ verified 98 targets out of
2,338 genes with reduced 30 UTR peaks in AGO2-IP samples is
surprising and suggests that our approach may not be effective
for filtering out all miR-124 targets. However, our data are
completely in line with other studies using HITS-CLIP (Tan
et al., 2013) and suggest that only a minority of targets bound
by a unique miRNA display altered mRNA-levels upon miRNA-
perturbation. Still, the list ofmiR-124 targets could increase since
some targets are likely regulated only at the protein level, which
could be interesting to study in the future using quantitative
high-throughput proteomics, or because of regulatory compen-
sation by other miRNAs or TFs. 38 of the identified miR-124
targets were already experimentally verified, and we further
validated 43 using luciferase reporter assays, demonstrating
the precision of our AGO2-RIP-seq approach for detecting
miR-124 targets in parallel. We detected higher apoptosis rates
in DmiR-124 neurons, which could be rescued by miR-124
overexpression. Hence, miR-124 regulation is essential for the
long-term survival of terminally differentiated neurons by
targeting directly but also indirectly a cascade of apoptosis-
relevant genes. This provides context to previous studies that
found miR-124 dysregulation in cases of Alzheimer disease
(AD) or cognitive impairment (Fang et al., 2012; Gascon et al.,
2014; Lukiw, 2007; Yang et al., 2014), suggesting that alterations
in miR-124 may be linked to neurodegenerative disorders via
control of apoptosis and neuronal survival, although these obser-
vations are controversial (De Strooper and Karran, 2016; Patrick
et al., 2017). Our findings highlight the need for cell-type precision
for linking certain miRNAs to cellular functions or pathologies.
Sampling over many brain cell types might be misleading as
neurons die in neurodegenerative diseases; therefore, reduced
miR-124 levels are expected but not necessarily causally linked
to primarily affected cell types. However, our data robustly sup-
port miR-124’s neuroprotective function over time.
As 24 direct miR-124 targets were TFs, we were also inter-
ested in how the lack of miR-124 regulation affected theirCell Systems 7, 438–452, October 24, 2018 449
networks. We achieved this by a wTO analysis of time course
RNA-seq data. In contrast to previous miRNA-TF networks that
were based on in silico predictions (Guo et al., 2010a), our target
TF networks were computed from experimentally obtained RNA-
seq data. Our recently developed wTO analysis allowed us to
specifically account for both positive and negative correlations,
which is crucial for analyzing regulatory networks that include
transcriptional activators and repressors (Gysi et al., 2017;
Nowick et al., 2009). Particularly, we found multiple yet unchar-
acterized zinc finger proteins such as ZNF787 associated with
miR-124 function. To start functionally characterizing ZNF787,
we overexpressed ZNF787 and found many biological pro-
cesses for neuronal development and functions to be signifi-
cantly reduced. We thus directly characterized this hereto
uninvestigated ZNF as a neuronal feature repressor. Several
other ZNFs targeted by miR-124 are human- or primate-specific
(i.e., ZNF138,ZNF37,ZNF701, and ZNF649), suggesting that pri-
mate-specific regulators may have an impact on neuronal differ-
entiation in humans. Besides impacts on coding transcripts, our
AGO2-RIP-seq, sRNA-seq and nCounter data further enabled us
to study miRNA species in DmiR-124 neurons that are normally
very likely outcompeted by miR-124 for RISC incorporation in
WT neurons. This dynamic change in miRNA regulation most
likely masked and thereby reduced molecular outcomes in
DmiR-124 cells and generally has to be taken into account
when studying specificmiRNA knockouts.Without studying indi-
rect gene regulatory TF-network effects and dynamic miRNA
profile changes, a sophisticated interpretation of miRNA manip-
ulation data will be challenging and incomplete.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Lines
iNGN cells (https://www.encodeproject.org, accession number: ENCBS369AAA) were previously described (Busskamp et al.,
2014a). hiPSCs were cultured in mTeSR 1 media (05850, StemCell Technologies) on standard tissue culture plates coated with
hESC-qualified Matrigel matrix (354277, Corning, incubated 45 min at room temperature) under standard conditions (5 % CO2,
37C). For passaging, hiPSCs were dissociated with TrypLE Express (12604013, Thermo Fisher Scientific), washed with DPBSe2 Cell Systems 7, 438–452.e1–e8, October 24, 2018
(pH 7.2; 14190169, Thermo Fisher Scientific), spun down (400 3 g) and replated using mTESR with 3 mg/ml InSolution Y-27632 rho
kinase inhibitor (688001, Merck Millipore) or frozen in mFreSR media (05854, StemCell Technologies).
CRTD5 hiPSCs were generated from BJ fibroblasts (CRL-2522, ATCC) at the CRTD iPS facility. Reprogramming was perfomed
using the CytoTune-iPS 2.0 Sendai Reprogramming Kit (Thermo Fisher Scientific) according to the manufacturer’s guidelines for
transduction. Following transduction, the cells were cultured with ReproTeSR medium (05920, StemCell Technologies) on hES-
qualified Matrigel for 18 to 21 days. Once stem cell colonies were sufficiently grown, the clonal colonies were mechanically isolated
and expanded using mTeSR medium. Passaging was carried out similarly to iNGN cells. ReLeSR (05872, StemCell Technologies)
was used for detachment in clumps. Pluripotency of the hiPS cells was tested using flow cytometry with Alexa Fluor 488-coupled
anti-Oct3/4 (560253), PE-coupled anti-Sox2 (560291), V450-coupled SSEA-4 (561156) and Alexa Flour 647-coupled anti Tra-1-60
(560850, all BD Pharmingen) according to the manufacturer’s protocol (Figure S2K). Furthermore, CRTD5 cells were tested positive
for their differentiation capability for all three germ layers (data not shown). Karyotyping was performed as stated for iNGN WT/
DmiR-124 cells (Figure S2L).
Stable integration of an inducible Neurog1/2 cassette to generate CRTD5-iNGN cells was performed using the PiggyBac trans-
poson system. All promoter elements and open reading frames between the 5’ core insulator and the SV40 polyA of the PiggyBac
vector backbone PB-TRE-dCas9-VPR13 (Addgene plasmid #63800; Chavez et al., 2015) were removed using SpeI/SalI and replaced
with PCR-amplified Neurog1/2 after a doxycycline-inducible promoter from the lentiviral iNGN construct (Addgene plasmid #61471;
Busskamp et al., 2014a). Plasmids were transformed into chemically competent bacteria for amplification (One Shot Stbl3, Thermo
Fisher Scientific). 10 mg of the plasmid were mixed with 2 mg of Super PiggyBac Transposase Expression Vector (PB210PA-1-S,
Biocat) and electroporated to CRTD5 cells with the Lonza 4D X-unit, pulse CB-156 and the P3 Primary Cell 4D-Nucleofector Kit L
(V4XP-3024, Lonza).
293T/17 cells (CRL-11268, ATCC) were cultured with DMEM + 10 % FBS (41966052, 10100147, Thermo Fisher Scientific) and
passaged with trypsin-EDTA (25300054, Thermo Fisher Scientific).
METHOD DETAILS
Neurogenin-1/2-Induced Differentiation
0.5 mg/ml doxycycline (D9891, Sigma-Aldrich) was used to induce Neurog1 and -2 genes. After 4 dpi, half of the mTeSR 1media was
replaced with supplemented BrainPhys media (05790, StemCell Technologies), replaced daily until 7 dpi and further once per week.
The following BrainPhys supplements were used for 10 ml media: 200 ml NeuroCult SM1 Neuronal Supplement (05711, Stemcell
Technologies); 100 ml N2 Supplement-A (17502048, Thermo Fisher Scientific); 20 ml of 10 mg/ml recombinant human BDNF to a final
concentration of 20 ng/ml (450-02, Peprotech); 20 ml of 10 mg/ml recombinant human GDNF to a final concentration of 20 ng/ml
(450-10, Peprotech); 98 ml of 50 mg/ml dibutryl-cAMP to a final concentration of 1 mM (D0627, Sigma-Aldrich); 50 ml of 40 mM
ascorbic acid to a final concentration of 200 nM (A0278, Sigma-Aldrich); and 100 ml of 1003 penicillin-streptomycin (15140122,
Thermo Fisher Scientific). After stable integration of the Neurog1/2 cassette to CRTD5 cells, the cells were differentiated similarly
to iNGN cells.
iPSC Differentiation into mDA Neurons
Midbrain dopaminergic (mDA) neurons were generated via a small-molecule-based protocol (Reinhardt et al., 2013). For neural
induction, confluent iPSCs were disaggregated using Accutase and subsequently resuspended as clumps in N2B27 medium
(Neurobasal-A (10888022), DMEM-F12 (11330032), N2 (17502048), B27 (12587010), GlutaMAX (35050061), 15 mM HEPES
(15630080); Thermo Fischer Scientific) supplemented with 1 mMdorsomorphin (3093, Tocris), 10 mMSB431542 (ab120163, Abcam),
5 mMROCK inhibitor (Y-27632, 688001, Merck), 3 mMCHIR (CHIR-99021, Tocris), 200 mMascorbic acid (AA, A0278, Sigma-Aldrich),
and 0.5 mM purmorphamine (PMA, sc-202785, Santa Cruz Biotechnology) via embryoid body formation. Six days after neural induc-
tion, embryoid bodies were dissociated into smaller pieces using a 1000 ml pipette and plated on Matrigel (Corning)-coated 12-well
plates. For expansion, smNPCs were cultured using N2B27 medium supplemented with 3 mM CHIR, 0.5 mM PMA, and 200 mM AA.
To differentiate mDA neurons, smNPCs were patterned by plating smNPCs into N2B27 medium containing 0.5 mM PMA, 2 ng/ml
human BDNF (450-02), 1 ng/ml GDNF (450-10, both Peprotech), and 200 mM AA. Maturation was induced by switching the medium
to N2B27 medium containing 2 ng/ml BDNF, 2 ng/ml GDNF, AA, 1 ng/ml TGF-b3 (100-36E, Peprotech), 100 mM dibutryl-cAMP
(D0627, Sigma-Aldrich), and 2 ng/ml activin A (120-14, Peprotech, first 2-3 days 5 ng/ml). For immunocytochemistry, differentiating
mDA neurons were replated as single cells on day 14 of the differentiation onto coverslips and fixed on day 21. NEUN expression was
quantified by counting positively stained nuclei using Fiji. Data were tested for significance using an unpaired Student’s t-test. Data
are presented as mean ± SEM.
Knockout of miR-124 Loci in Human iPSCs
sgRNA were designed by the MIT’s CRISPR web tool (http://crispr.mit.edu/; Hsu et al., 2013). sgRNA sequences and corresponding
oligos were used according to Table S2. All oligos were cloned into the vector pSpCas9(BB)-2A-Puro (PX459) V2.0 (a kind gift from
Feng Zhang, Addgene plasmid #62988) as described in Ran et al. (2013). Four different sgRNA-expressing constructs were co-elec-
troporated (10 mg per vector) into iNGN and CRTD5 cells by the Lonza 4D X-unit, pulse CB-156, and the P3 Primary Cell 4D-Nucle-
ofector Kit L (V4XP-3024, Lonza), according to the manufacturer’s guidelines. Cells were plated sparsely, and selected for PX459Cell Systems 7, 438–452.e1–e8, October 24, 2018 e3
integration after 24 h with puromycin. Grown colonies, derived from single cells, were picked and genotyped with primers specific for
all miR-124 loci (Table S3) using the Kapa Hifi Mastermix (KR0370, Kapa Biosystems) or Takara PrimeStar Max Mastermix (R045B,
Takara Bio) according to the manufacturer’s protocol.
Potential off-targets (score % 0.9 according to design tool; http://crispr.mit.edu/; Hsu et al., 2013) were tested by Sanger
sequencing of corresponding PCR products that were amplified from genomic DNA using specific primers for the iNGN cell line
(Table S4). 20 metaphase states from each cell line were karyotyped using G-banding (Shaw, 1973) via the iPS facility of the Center
for Molecular and Cellular Bioengineering (CMCB) at the Institute of Human Genetics, University Clinics Jena, Germany, to test for
chromosomal alterations.
Imaging and Image Analysis
Fluorescence imaging was performed on a Zeiss Axio Observer Z1 inverted fluorescencemicroscope. Images were processed using
Fiji; the imageswere adjusted in the sameway for every picture and channel from each experiment. Microscopic characterization and
quantification of phenotypic differences were performed using an EVOS FL system (ThermoFisher Scientific) and manual counting
using Fiji. Qualitative Brightfield images and images showing GFP expression of live cells were corrected for equal illumination
throughout the well. Statistical comparison of morphological parameters was performed using an unpaired Student’s t-test for
two groups. Data are presented as mean ± SEM.
miR-124 and ZNF787 Overexpression
For miR-124 overexpression, a doxycycline-inducible promoter, the genomic miRNA-124 locus (±100 bp) placed within the human
beta-globin intron (from pCMV-MIR vector, Origene) and a GFP-puromycin reporter were inserted into the SpeI/SalI linearized
PiggyBac vector backbone PB-TRE-dCas9-VPR13 (Addgene plasmid #63800; Chavez et al., 2015) using isothermal assembly
(Gibson et al., 2009) leading to the miR-124 expressing construct PB09-TRE-EF1a-beta-globin-miR-124-GFP-TetO-Puro. The
control construct PB09-TRE-EF1a-beta-globin-miR-ctrl-GFP-TetO-Puro (EGFP-ctrl) was identical to PB09-TRE-EF1a-beta-
globin-miR-124-GFP-TetO-Puro, but lacked the miR-124 hairpin, which resulted in a less bipolar ground state of the neurons due
to the high GFP expression. The respective constructs were electroporated into iNGN cells and after two days selected for stable
integration using 3 mg/ml puromycin. ZNF787 overexpression was performed using the same PiggyBac vector (PB-TRE-dCas9-
VPR13) with addition of a doxycycline-inducible promoter, PCR-amplified ZNF787 (variant 1), a V5 tag and a blasticidin resistance
gene after via isothermal assembly (construct PB09-TRE-ZNF787-V5-Blasti). Stable integration was assured by administration of
15 mg/ml blasticidin for at least three days.
Quantitative Real-Time PCR
For gene expression analysis, 250,000 cells of each corresponding sample group were seeded onto Matrigel-coated 12-well plates
and induced with doxycycline. At 4 dpi, cells were detached with TrypLE Express (12604013, Thermo Fisher Scientific), spun down,
and lysed with Qiazol (miRNeasy Mini Kit, 217004, Qiagen). The phases were separated with Phase Lock Gel tubes (heavy, 2 ml,
733-2478, 5PRIME) and the aqueous phase was cleaned-up with the miRNeasy Kit. 500 ng of the resulting RNA was reverse tran-
scribed with the High-Capacity cDNA Reverse Transcription Kit (4368814, Thermo Fisher Scientific) or, for miRNA-specific analysis,
the Universal cDNA Synthesis Kit with 5 ng input, respectively (203301, Exiqon). Primers for miR-124 were purchased from Exiqon/
Qiagen (YP00206026). At least three biological replicates were used per sample and normalized to 5S RNA (YP00203906, Exiqon/
Qiagen). For ZNF787, the expression analysis was conducted with ZNF787-specific primers and normalized to beta-Actin
(ZNF787_for, CCAGTCACGAGAACCCAGTG, ZNF787_rev, CTCTGCGAGAAGGTCTTGCC; ACTB_for, CCTCGCCTTTGCCGATCC;
ACTB_rev, CGCGGCGATATCATCATCC). Quantitative measurements were performed with the StepOnePlus Real-Time PCR
System (Thermo Fisher Scientific) and Power SYBR Green PCR Master Mix (4367659, Thermo Fisher Scientific). Statistical compar-
ison was based on the delta-delta-Ct method and performed using unpaired Student’s t-tests and Holm-Sidak correction for multiple
comparisons. Data are presented as mean ± SEM.
SDS/Page Electrophoresis and Western Blot
For sample preparation, cells were lysed in RIPA buffer (R0278, Sigma-Aldrich) mixed with protease inhibitor cocktail (1:25, 118735,
Sigma-Aldrich) for 45 min on ice. Cells were then centrifuged at 10,000 3 g for 10 min at 4C. The supernatants were collected and
transferred to a fresh tube. Samples were boiled at 95C for 5min in Laemmli buffer (1610737, BioRad). Proteins were separated on a
4–12 % SDS/PAGE gel. Gels were then transferred using the Transblot-Turbo Transfer system (BioRad). After transfer, membranes
were blocked for 1 h in Tris-buffered saline (T5912, Sigma-Aldrich) with 0.1 % Tween20 (TBST, P1379, Sigma-Aldrich) and 5 %
(wt/vol) non-fat dry milk (70166, Sigma-Aldrich) followed by overnight incubation at 4C. The primary antibody was mouse anti-
AGO2 (1:1,000; SAB4200085, Sigma-Aldrich). After two TBST washing steps of 15 min, membranes were incubated for 1 h at
room temperature with HRP-conjugated secondary antibodies: anti-mouse (1:5,000; sc-2005, Santa Cruz Biotechnology). Actin
staining was done using a monoclonal mouse anti-b-actin HRP (1:100,000; A3854, Sigma-Aldrich). Membranes were developed
with the ECL Prime Western Blotting Detection Reagent (RPN2232, GE Healthcare). The signal was measured using a Chemidoc
MP system (BioRad) and band intensities were quantified by densitometry using the ImageJ software.e4 Cell Systems 7, 438–452.e1–e8, October 24, 2018
Neurite Outgrowth Assay
iNGN cells (WT or DmiR-124) were seeded at a density of approximately 50,000 cells/cm2 and induced with 0.5 mg/ml doxycycline.
At 4 dpi, clusters of neurons were mechanically detached with a pipette tip und transferred to a PDL-laminin-coated 96-well plate for
imaging (655090, Greiner). The next day pictures were taken every 10min over a total time of 1 hwith a Leica DMI6000 live-cell cham-
ber. Neurite length was manually quantified from frame to frame using Fiji. Statistical comparison was performed using an unpaired
Student’s t-test for two groups. Data are presented as mean ± SEM.
Flow Cytometry
Cells were detached using TrypLE Express (12604013, Thermo Fisher Scientific), washed with DPBS without calcium and magne-
sium (14190169, Thermo Fisher Scientific), stained with PE-anti-TRA-1-60 (560193, BD) or the isotype control (555584, BD) and
Brilliant Violet 421-anti-NCAM (318328, Biolegend) or the isotype control (400157, Biolegend). After staining for 1 h on ice, the cells
were resuspended in FACS buffer comprising DPBS, 10 % fetal bovine serum (26140-079, Thermo Fisher Scientific), and 10 mM
EDTA (15575-038, Thermo Fisher Scientific). A BD LSR II flow cytometer and BD FACSDiva software were used for analysis. Median
fluorescence signal was used as measure for marker expression. Statistical comparison was performed using unpaired Student’s
t-tests and Holm-Sidak correction for multiple comparisons. Data are presented as mean ± SEM.
Apoptosis and Viability Assay
WT and DmiR-124 were seeded and differentiated consecutively according to the time frame from 0 to 14 dpi and all samples were
measured with a SynergyNeo2 plate reader (BioTek) on the same day. The ApoToxGlo assay (G6320, Promega) was conducted
according to the manufacturer’s protocol. Statistical comparison was performed using unpaired Student’s t-tests and Holm-Sidak
correction for multiple comparisons. Data are presented as mean ± SEM.
Luciferase Reporter Assays
3’ UTRs of potential miR-124 targets from the RIP-Seq Analysis were cloned into the pmiRGLO-SMAD4 vector (a gift from Heidi
Schwarzenbach, Addgene plasmid #78128) (Eichelser et al., 2014) using NheI and XbaI, together with specific primers for the 3’
UTR region (Table S5). A reversedmiR-124 sponge sequence – not bindingmiR-124 – served as negative control for the assay. These
constructs were transfected into four independent replicates of 293T/17 cells together with a miR-124 overexpressing construct
(pSMPUW-miR-GFP-Puro with integrated miR-124 according to the manufacturer’s protocol; or a control construct (Cell Biolabs)
using polyethylimine ‘Max’ (24765-2, Polyscience). 48 h after transfection, the cells were harvested using the dual-luciferase assay
kit (E1910, Promega). Luciferase activity (firefly and renilla) was monitored using a SynergyNeo2 (BioTek) (Table S6), normalized to
the negative controls and tested for significance using unpaired Student’s t-test and Holm-Sidak correction for multiple compari-
sons. Data are presented as mean ± SEM.
Electrophysiological Measurements
During the experiment, single cover slips with WT or DmiRNA-124 neurons were kept in filtered (0.2 mm) extracellular solution of the
following composition (mM): NaCl 130 (S3014, Sigma-Aldrich), HEPES 20 (15630056, ThermoFisher Scientific), glucose 10 (CRTD
media kitchen), KCl 5 (1049360250, Merck), CaCl2 2.5 (CRTD media kitchen), MgCl2 (CRTD media kitchen), pH 7.3 with NaOH
(1064950250, Merck). Neurons were localized under an upright microscope (Zeiss Examiner.A1 Axio) equipped with a water-
immersion 203 objective (420957-9900, Zeiss). Neurons were selected for single-cell patch-clamp using whole-cell configuration.
Microelectrodes had resistances of 6 MU, were pulled from borosilicate glass (GB150EFT-8P, Science Products) with a P-1000
programmable horizontal puller (Sutter Instruments), and contained a filtered (0.2 mm) intracellular solution of the following compo-
sition (mM): KCl 130, HEPES 20, EGTA 10 (324626, Merck), CaCl2 0.25, pH 7.3 with KOH. The head stage was attached to a digitally
controlled micro-manipulator (Luigs & Neumann SM-7) and connected to a multi-clamp 700 amplifier (Molecular Devices): analogue
electrophysiological data were low-pass filtered at 6 kHz and subsequently converted to digital values at a sample rate of 20 kHz
using a Digidata 1440A (Molecular Devices). Data was transferred to a PC using pClamp software (10.3, Molecular Devices) and
analyzed using Clampfit software (10.3, Molecular Devices) and custom Python code with the neo package (neo.readthedocs.io).
Pipette capacitance was always compensated for. For each neuron, several 10 mV pulses were applied after opening the cell to
measure the capacitance in voltage-clampmode at60mV and subsequently averaged. Capacitance was calculated as the integral
of the capacitive current (carried charge) at offset of pulse, divided by the pulse amplitude. Cell capacitance was compensated for
before further voltage clamp recordings. Peak and steady-state currents were analyzed by applying incremental depolarizing voltage
pulses from 60 to 55 mV in 5 mV steps. Membrane potential was taken as the median of a 30 s recording in current-clamp mode
(I = 0). Spiking behavior was assessed by injecting constant current to hold cells at around 70 mV. To find a neuron’s maximum
number of spikes, 500 ms increasing current steps were injected from30 to 150 pA in 10 pA steps. Action potentials were detected
using a threshold at10mV. All membrane voltages were corrected for a liquid junction potential, which was calculated to be 0.4mV.
No cover slip was measured for longer than 1 h.
Immunocytochemistry
Cells were grown on Matrigel-coated glass coverslips and fixed for 10–15 min with 4 % paraformaldehyde (15713, Electron
Microscopy Sciences) in PBS (14040-117, ThermoFisher Scientific) and subsequently washed twice with PBS. PermeabilizationCell Systems 7, 438–452.e1–e8, October 24, 2018 e5
and blocking was performed using 10 % NDS (S30-100ML, Merck-Millipore), 0.5 % Triton X-100 (Sigma Aldrich), and 1 % BSA
(15260037, ThermoFisher Scientific) in PBS for 20 min. Primary antibodies were applied overnight at 4C in 3 % NDS in PBS. Sub-
sequently, the samples were washed (10 min) three times with PBS, the secondary antibodies and DAPI (10236276001, Sigma-
Aldrich) were applied for 1 h at room temperature in 3 % NDS in PBS. Three washes (10 min) with PBS-T (0.05 % Tween-20,
P1379-250ML, Sigma Aldrich) were performed. Cells were mounted in Prolong Gold Antifade (P36934, Thermo Fisher Scientific).
Primary antibodies used in this study were mouse anti-NESTIN (1:300, MAB1259, R&D), goat anti-SOX1 (1:300, AF3369, R&D),
rabbit anti-PAX6 (1:300, 901301, Biolegend), goat anti-SOX2 (1:300, 17320, Santa Cruz), mouse anti-FOXA2 (1:300, 101060, Santa
Cruz), rabbit anti-TH (1:300, AB152, Merck Millipore), chicken anti-TUBBIII (1:700, AB9354, Merck Millipore), chicken anti-MAP2
(1:700, ab92434, Abcam), mouse anti-NEUN (1:700, MAB377, Merck Millipore), mouse anti-NCAM (1:700, 610921, BD), goat anti-
DCX (1:700, sc-8066, Santa Cruz), rabbit anti-GFAP (1:700, ab16997, Abcam), and rabbit anti-dopamine (1:300, AB122S, Merck
Millipore). Secondary antibodies were obtained from Thermo Fisher Scientific and were conjugated to AlexaFluor fluorochromes
(1:1,000). Anti-rabbit-Cy3 (1:1,000, 711-165-152, Jackson labs) was also used.
RNA-Interacting Protein Immunoprecipitation
Cell pellets from approximately 50 million cells were homogenized, lysed in ice-cold lysis buffer (10 mM HEPES (pH 7.3,
ThermoFisher Scientific), 100mMKCl (1049360250,Merck), 0.5%NP40 (NP40S, Sigma-Aldrich), 5mMMgCl2, 0.5mMdithiothreitol
(DTT, DTT-RO, Sigma-Aldrich), protease inhibitors (118735, Sigma-Aldrich), recombinant RNase inhibitors (10777019, ThermoFisher
Schientific), 1 mM PMSF (36978, ThermoFisher Scientific) using TissueLyser LT (50 Hz, 2 min, Qiagen). For lysate clearing, homog-
enates were centrifuged for 15min at 16,2003 g, 4C. A 50 ml sample was taken as a pre-IP sample. The RIP samples were incubated
with Dynabeads Protein G beads (10009D, ThermoFisher Scientific) coated with anti-hAGO2 antibody (a gift from JA Nelson) (Grey
et al., 2010) for 24h at 4C with end-over-end rotation. After incubation, beads were collected on a Dynamagnet (1 min, on ice, Ther-
moFisher Scientific) and gently resuspended in low-salt NT2 buffer (50 mM Tris-HCl (pH 7.5, T1503, Sigma-Aldrich)), 1 mM MgCl2,
150 mM NaCl (S3014, Sigma-Aldrich), 0.5 % NP40, 0.5 mM dithiothreitol, 1 mM PMSF, protease inhibitors, recombinant RNase in-
hibitors). The beads were transferred to a new collection tube and washed with low salt NT2 buffer, followed by two washes with high
salt NT2 buffer (50 mM Tris-HCl, pH 7.5), 1 mM MgCl2, 600 mM NaCl, 0.5 % NP40, 0.5 mM DTT, protease inhibitors, 1 mM PMSF,
recombinant RNase inhibitors). The solution containing the RNA was then transferred to Qiazol (Qiagen). Subsequently, RNA was
isolated from RIP and pre-RIP samples according to the miRNeasy micro kit protocol (217084, Qiagen). The size distribution of
the samples and the quality was checked with a Bioanalyzer RNA 6000 Pico Chip (5067-1513, Agilent Genomics).
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical details for each experiment are described in the Results and corresponding Methods sections as well as in the
Figure legends.
Sequencing and Analysis of RIP Samples
cDNA libraries of three independent WT whole-cell RNA, DmiR-124 whole-cell RNA, WT-AGO2 RIP, and DmiR-124-AGO2 RIP sam-
ples for 0 and 4 dpi were prepared using NEBNext Ultra I Directional RNA Library Prep Kit for Illumina (E7420, NEB) with 900 ng input
at the CMCB Sequencing Facility at TU Dresden (Table S7). PolyA selection, fragmentation, first strand and second strand cDNA
synthesis, and purification were performed in combination with Agencourt AMPure Kit (A63880, Beckman Coulter) and repair/
dA-tailing of the cDNA. Adapters were ligated to dA-tailed cDNA and size-selected using AMPure XP Beads (Beckman Coulter).
RIP samples were not polyA-selected. Index primers (Illumina) were used to index library constructs, and a PCRwas performed using
NEBNext Q5 2X PCR Master Mix (M0543S, NEB). Libraries were purified using Agencourt AMPure Kit. Libraries were pooled and
sequenced on a HiSeq 2500 (Illumina), resulting in ca. 33-56 million single-end 75 bp reads.
RIP-Seq reads were pre-processed (includes demultiplexing, barcode trimming, and adaptor removal) using BBDuk from the
BBMap toolkit (github.com/BioInfoTools/BBMap, v36.14). After quality control with FASTQC (bioinformatics.babraham.ac.uk/
projects/fastqc/, v0.11.4), reads were mapped to the human genome assembly hg38/GRCh38 using Segemehl (bioinf.uni-leipzig.
de/Software/segemehl/, v0.2.0-418). Uniquely mapped reads were extracted for further analysis.
For differential expression analysis of the whole-cell RNA-Seq data reads were mapped to the human reference genome (hg38)
using GSNAP (research-pub.gene.com/gmap/) with ENSEMBL annotation 81 and counted using featureCounts (http://bioinf.
wehi.edu.au/featureCounts/; v1.5.2). Differential expression analysis was performed using DESeq2 (bioconductor.org/packages/
DESeq2/; Love et al., 2014) on uniquely mapped reads.
RIP-Seq Binding Site Definition and Filtering
RIP-Seq identifies target transcripts/genes, sacrificing the high resolution of CLIP-Seq for the advantage of not performing a cross-
linking procedure. Higher resolution and crosslinking techniques such as CLASH or CLEAR-CLIP, will most likely identify additional
and lower abundant targets. However, a key aspect of our study is the combination of native AGO2-IP with expression data derived
from RNA-Seq. This allows to normalize IP signal to target expression, adding a quantitative layer to our data, which was used
to compare relative levels of miRNAs andmiRNAs associated with the RISC complex betweenWT and DmiR-124 cells. The resulting
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validated targets as well as predicted targets (Tables S7, S8, and S9). These target predictions were conducted with seed regions,
starting from a length of 6 nts. The combination of validated and predicted targets leads to a list of annotated miR-124 targets,
rendering this initial set of targets most likely too large. Our AGO2-RIP-Seq data allowed us to identify bona fide miR-124 targets
in iNGN cells, and relate our findings to well-established databases: the results confirm that we had identified biologically relevant
targets. A binding site is defined as a region with a significantly higher number of read pile-ups than would be expected by chance
at a given genomic position. We used a custom filtering method to split potential binding regions once certain height thresholds were
reached. Cutoffs were defined based on signals detected in known miR-124 targets. Regions with a summit signal below 10 read
pile-ups are considered background and were discarded. With a sliding window approach, starting from the summit, a binding
site is first split when its height falls below 20 % of the summit signal. Emerging sub-sites with a summit above this cutoff and
10 pile-ups are then recursively split when their signal falls below 5 % of their summit, which also preserves regions with only
weak signal. Replicates of each experimental setup were analyzed separately, and only peaks occurring in all replicates were
considered for further analysis. Binding sites derived from uniquely mapped reads were annotated using the ENSEMBL Perl
API for human annotation v90. Data were filtered using R and Excel (Microsoft) using Targetscan, miRanda, RNA22, and miRWalk
(Dweep et al., 2011; John et al., 2004; Lewis et al., 2005; Miranda et al., 2006). Furthermore, miRTarBase for experimentally validated
miRNA-mRNA interactions was used to extract validated targets of miR-124 (Hsu et al., 2011).
RNA-Seq from Total RNA, Processing and Data Analysis
Samples were prepared as for qRT-PCR analysis in seven biological replicates for sequencing of total RNA using the miRNeasy mini
kit (Qiagen) and Phase Lock Gel tubes (heavy, 2 ml, 733-2478, 5PRIME) for enhanced phase separation according to the manufac-
turer’s guidelines. cDNA libraries were prepared as RIP-Seq samples. Fasta files were processed and controlled for quality as RIP-
Seq. Counts were computed using rnacounter (https://github.com/jdelafon/rnacounter) using RPKM and raw counts, from the v25
gencode annotation (Tables S12 and S13). Data comparing WT, DmiR-124 and ZNF787 overexpression were mapped and counted
similarly to RIP-Seq whole-cell samples (Table S14). Differential expression (DE) and principal component analysis was calculated
using DESeq2 with raw counts. The contrast used was DmiR-124 versusWT. Normalized fold changes (nFC) of the significant genes
(Benjamini & Hochberg adjusted p-values < 0.05; Benjamini and Hochberg, 1995) were used to construct the timecourse analysis.
Z-scores were used to visualize expression analysis per gene. For the ZNF787-associated genes, counts were rlog-transformed with
DESeq2 prior to standardization.
Small RNA Quantification and Analysis
For small RNA sequencing (sRNA-Seq), cDNA libraries were prepared using NEXTFlex Small RNA Library Prep V3 (NOVA-5132-06,
BIOOScientific) with 50 ng input and 22 PCR cycles. Sequencing was performed using a HiSeq 2500 (Illumina). A similar approach as
used for RIP-Seq analysis was also applied to sRNA-Seq data. After pre-processing, quality control, andmapping, read profiles were
filtered using the same custom approach as for RIP-Seq data (Table S10). Due to the nature of sRNA-Seq data, multi-mapped reads
were considered, but were neglected for the differential expression analysis. Regions that passed the filtering steps and were called
in all replicates were again annotated using the ENSEMBL Perl API v90; peaks overlapping miRNA annotation were selected for
downstream processing. Differential expression analysis was performed using DESeq2 on uniquely mapped reads as with RNA-
Seq data. Complementarily, the nCounter human miRNA panel v3 (CSO-MIR3-12, NanoString) from 100 ng total RNA isolated, as
stated for RNA-Seq, was used in combination with the Prep Station and the Digital Analyzer according to the manufacturer’s guide-
lines. nCounter-miRNA counts were analyzed similarly to sRNA-Seq counts using DESeq2 (Table S11). For the computation of
expression profiles, nCounter-derived raw counts were normalized to the corresponding counts of housekeeping genes on a per-
replicate basis. The mean-normalized counts were used for data visualization. Of note, the nCounter miRNA Expression Assay kit
did not include probes for all human miRNAs and not all miRNA probes were optimal (Busskamp et al., 2014a). For our analysis,
we only focused on miRNAs that passed an nCounter threshold of >200 raw counts (corresponding to 0.004 normalized counts
to housekeeping genes) at least in one of the 12 samples.
Neuronal Profiling Using BrainSpan Atlas
To align the iNGN read data to the human genome (hg38/hg19), TopHat2 v2.1.0 (Tuxedo suite; Trapnell et al. (2012); ccb.jhu.edu/
software/tophat) was used. We determined the gene expression levels (FPKM) and the differentially expressed (DE) genes using
Cuffdiff (http://cole-trapnell-lab.github.io/cufflinks/cuffdiff/, v2.2.1; Gencode v26/v10). To identify the genes related to brain devel-
opment, we calculated the 1,000 highest DE genes of theWT andDmiR-124 cells at 4, 7 and 14 dpi with respect to 0 dpi, respectively.
Subsequently, the Pearson correlation coefficient was derived for the remaining FPKMs of each BrainSpan sample and our cell lines
at 4, 7 and 14 dpi. The BrainSpan Atlas by the Allen Institute (www.brainspan.org; Miller et al., 2014) contains RNA-Seq data from
16 cortical and subcortical brain regions from both female and male human individuals. The samples span from 8 postconceptional
weeks to 40 years (29 timepoints in total). In order to test whether a brain region had a higher correlation to any given age, we deter-
mined if the differences in means was larger than twice the standard deviation of samples with a similar age. For all analyses, we
combined cerebellum and cerebellar cortex data from the BrainSpan Atlas since their timepoints did not overlap and calculated
themean of the FPKMs between individuals for each timepoint and region. Graphical brain illustrations were performed as previously
described (Hawrylycz et al., 2012).Cell Systems 7, 438–452.e1–e8, October 24, 2018 e7
Self-Organizing Map Clustering
TFs that were differentially expressed at all timepoints from 1 to 4 dpi were clustered according to their nFC pattern over time using
the Self Organizing Maps (SOM) algorithm (Kohonen et al., 1996), implemented in R using the package som (https://CRAN.R-project.
org/package=som). The number of clusters was increased until the q-error of each group was reduced, with the average distortion
measure under 10. The membership of the genes to each SOM cluster was used to color the genes in the (target-) TF-TF network
analysis.
Weighted Topological Overlap (wTO)
The wTO is a measure of how a set of genes of interest is correlated. Having a high absolute wTO means that the expression of both
genes is highly (positively or negatively) correlated. The wTO computes not only the signed weight of this relationship, but also the
probability of the relationship being random. The R package wTO (https://cran.r-project.org/web/packages/wTO/index.html; Gysi
et al., 2017) was used to calculate the wTO of the (target-) TF-TF networks (Table S15). The correlation between a set of genes
was corrected using all the other genes present, thus reducing the noise and the false positives, and taking into account the com-
monalities of those genes. The parameters used in this calculation were Pearson product-moment correlation coefficient and 1000
bootstraps resampling. The final results were filtered to a probability of 0.10 for having random wTO. The wTO was calculated based
on RPKM values. Genes with RPKM < 5 for each day were removed. From the total of 56269 mapped transcripts from the RNA-Seq
dataset, 39,275 are considered to be expressed, using the criteria previously described. Only TFs from the RIP-Seq high probability
target list (assembled from the Gene Regulatory Factor (GRF) Catalog (Berto et al., 2016) were considered for the network analysis:
these are associated with gene ontology terms for regulation of transcription, DNA-dependent transcription, RNA polymerase II tran-
scription co-factor and co-repressor activity, chromatin binding, modification, remodeling, or silencing, among others. The wTO
R package was used to visualize the interactive plots. igraph (igraph.org/r/) and network (CRAN.R-project.org/package=network)
R packages were used to visualize the developmental network. Human or primate specificity was judged according to the Uniprot
database (uniprot.org).
GO Enrichment Analysis
GO enrichment analysis was conducted using the R package topGO (bioconductor.org/packages/topGO) using all expressed genes
(TPM > 0.01 or average RPKM > 10) as background for each day. The GO enrichment analysis for days 7 and 14 was done separately
for up- and down-regulated genes, according to the DE analysis. Semantic clustering was performed with REVIGO (revigo.irb.hr)
using the SimRel measure and allowed similarity of 0.9).
Co-expression Differential Network Analysis (CoDiNA)
Identifying similarities and differences between the WT and DmiR-124 wTO-TF networks was performed using the CoDiNA method
implemented in the R package CoDiNA (Table S1) (Gysi et al., 2018), a recently-developed method to classify links and nodes ac-
cording to F categories, to its commonalities, differences and specificities. Links are considered to be common (a) if they belong
to a set of networks (WT and DmiR-124 for each day) with the same sign and similar strength. If the sign changes from one network
to another, the link is considered different (b). If a particular link belongs to one network only, it is considered to be specific to this
network (g). a and b categories are intersections of correlated genes between WT and DmiR-124: g links are exclusive for one con-
dition. The classification of the interactions according to these concepts is central to understand how the DmiR-124 networks are
affected in their TF interactions during the time course. The distance of each link to the origin is calculated in order to score links
that are more common, different or specific. Links with a normalized F distance greater than 0.5 were kept for further analysis.
In order to define the category a TF belongs to, a c2 goodness-of-fit test was used to test if the distribution of the links is different
than 1/3 for each category (p < 0.05). Each TF is classified using the link category that appears most frequently for that particular TF.
The correlation between TFs and genes was measured using a Pearson product-moment correlation coefficient. Only absolute cor-
relations > 0.9 were considered to be correlated for the following analyses. CoDiNA was computed separately for each day. In order
to compare WT and DmiR-124 networks, the TFs were distinguished according to category; the names of the genes correlated with
the TF were retrieved. The GO enrichment analysis was performed as stated above.
DATA AND SOFTWARE AVAILABILITY
The RNA-Seq data discussed in this publication have been deposited in NCBI’s Gene Expression Omnibus and are accessible
through the GEO SuperSeries accession number GSE118316 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=
GSE118316). The wTO tool is available at https://CRAN.R-project.org/package=wTO and CoDiNA under https://CRAN.R-project.
org/package=CoDiNA. Raw counts for RNA-Seq data are also provided in Tables S7, S10, S12, S13, and S14. AGO2 binding signal
at the 3’ UTR is provided in Table S8. nCounter raw data are listed in Table S11. The high-probability miR-124 target list is provided as
Table S9. Luciferase assay raw data are listed in Table S6.e8 Cell Systems 7, 438–452.e1–e8, October 24, 2018
